Description
Overview:
MEDI-MIBI is a radiopharmaceutical preparation kit containing 500 micrograms of methoxyisobutylisonitrile (MIBI) ligand for labeling with Technetium-99m (99mTc). The resulting 99mTc-MIBI compound is extensively utilized in nuclear medicine for myocardial perfusion scintigraphy, enabling assessment of coronary artery disease and cardiac function. Additionally, it assists in detecting certain tumors due to its ability to localize in mitochondria-rich tissues.
Manufactured under stringent quality controls, MEDI-MIBI ensures high labeling efficiency, stability, and reliable imaging performance.
Key Features:
-
Supplied as a sterile, freeze-dried kit with 500 µg MIBI
-
Compatible with freshly eluted 99mTc-pertechnetate
-
High radiochemical purity and labeling yield
-
Ready for easy preparation in hospital radiopharmacies
-
Shelf-stable under recommended storage conditions
-
Compliant with international GMP and pharmacopeial standards
Applications:
-
Myocardial perfusion imaging (SPECT) for coronary artery disease diagnosis
-
Detection and localization of tumors and malignancies
-
Assessment of chemotherapy response
-
Research in nuclear cardiology and oncology
Reviews
There are no reviews yet.